Thyrocare Technologies Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Thyrocare Technologies Ltd. on BSE

Load latest

Thyrocare Technologies Ltd.

02 Feb 2024

983.00

-0.06%

Earnings Call

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

In compliance with Regulation 30(6) read with Part A of Schedule III of the Listing Regulations, we wish to inform that the audio recording of earnings conference call for Analysts and Investors held on February 01, 2024, at 6.00 p.m. with respect to the Company's financial results for quarter and nine months ended December 31, 2023, is available on the company's website https://investor.thyrocare.com/financials/quarterly-financial-results/.

pdf

Thyrocare Technologies Ltd.

01 Feb 2024

983.00

-0.06%

Company Update

Thyrocare Technologies Ltd - 539871 - Appointment Of Mr. Ankit Brijpuriya As Deputy Company Secretary And …

BSE India

Appointment of Deputy Company Secretary and Compliance Officer

pdf

Thyrocare Technologies Ltd.

01 Feb 2024

983.00

-0.06%

Thyrocare Technologies Results Earnings Call for Q3FY24

Conference Call with Thyrocare Technologies Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Thyrocare Technologies Ltd.

01 Feb 2024

983.00

-0.06%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the quarter and nine months ended December 31, 2023.

pdf

Thyrocare Technologies Ltd.

01 Feb 2024

983.00

-0.06%

Result

Thyrocare Technologies Ltd - 539871 - For The Quarter And Nine Months Ended December 31, 2023

BSE India

Financial Results for the quarter and nine months ended December 31, 2023.

pdf

Thyrocare Technologies Ltd.

01 Feb 2024

983.00

-0.06%

Board Meeting

Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for For Financial Results For The Quarter …

BSE India

1. the unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2023. 2. appointment of Mr. Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer of the Company w.e.f. February 01, 2024;

pdf

Thyrocare Technologies Ltd.

01 Feb 2024

983.00

-0.06%

Company Update

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

We wish to inform you that Thyrocare Technologies Limited has entered into Share Purchase Agreement with Think Health Diagnostics Private Limited and existing shareholders of Think Health on February 1, 2024 at 12:30 pm (IST) to acquire 100% stake in Think Health from all the existing shareholders of Think Health.

pdf

Thyrocare Technologies Ltd.

24 Jan 2024

983.00

-0.06%

Company Update

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Investor call intimation

pdf

Thyrocare Technologies Ltd.

24 Jan 2024

983.00

-0.06%

Board Meeting

Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Approval Of The Unaudited Financial Results …

BSE India

Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 ,inter alia, to consider and approve Board meeting intimation for Approval of The Unaudited Financial Results of The Company For The Quarter And Nine Months Ended 31St December 2023.

pdf